| Company Name: | ATC Healthcare, Incorporated | | Ticker Symbol: | AHN | | | WWW Address: | www.atchealthcare.com |
| CEO: | David Savitsky | | No. of Employees: | 74 |
| Common Issue Type: | CS | | Business Description: | The Company and its subsidiaries provide supplemental staffing to healthcare facilities through its network of 52 offices in 31 states.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Staffing & Outsourcing Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 0.09 |  0.0 | - | - | | 0.10 | 0.07 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 4.2 | 46.7 | 0.45 | -0.07 | 0.00 | 0.0 | 0.0 | 0.41 - 0.05 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 0.10 | $ | | PE Ratio - LTM | 0.0 | |
| Market Capitalisation | 4.2 | mil |
| Latest Shares Outstanding | 46.7 | mil |
| Earnings pS (EPS) | -0.07 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 1,208,122 | $ |
| Effective Tax Rate | 0.0 | % |
| Float | 41.7 | mil |
| Float as % of Shares Outstanding | 89.3 | % |
| Foreign Sales | | mil |
| Domestic Sales | | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 19.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 21.2 | % |
| EBITDA Margin | 1.4 | % |
| Pre-Tax Profit Margin | -2.4 | % |
| Assets Turnover | 3.5 | % |
| Return on Assets (ROA) | -7.3 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | -33.3 | % |
| Current Ratio | 1.0 | |
| Leverage Ratio (Assets/Equity) | 6.0 | |
| Interest Cover | 0.1 | |
| Total Debt/Equity (Gearing Ratio) | 3.20 | |
| LT Debt/Total Capital | 23.0 | % |
| Working Capital pS | 0.00 | $ |
| Cash pS | 0.01 | $ |
| Book-Value pS | 0.10 | $ |
| Tangible Book-Value pS | -0.04 | $ |
| Cash Flow pS | -0.04 | $ |
| Free Cash Flow pS | -0.06 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 1.00 | |
| Price/Tangible Book Ratio | -2.50 | |
| Price/Cash Flow | -2.5 | |
| Price/Free Cash Flow | -1.7 | |
| P/E as % of Industry Group | 0.0 | % |
| P/E as % of Sector Segment | 0.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 42.9 | 138 | 329 | 894 |
| 4 Weeks | 0.16 | 0.05 | 0.12 | -16.7 | 85 | 228 | 4,330 |
| 13 Weeks | 0.16 | 0.05 | 0.13 | -23.1 | 86 | 356 | 21,350 |
| 26 Weeks | 0.26 | 0.05 | 0.28 | -64.3 | 41 | 443 | 54,928 |
| 52 Weeks | 0.41 | 0.05 | 0.32 | -68.8 | 34 | 486 | 121,400 |
| YTD | 0.16 | 0.05 | - | -28.6 | 79 | 187 | 10,271 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 0.07 | 0.08 | 0.10 | 0.16 | 0.21 | 0.45 | 1.50 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | -12.89 | 56.1 | -4.53 |
| Income | 0.00 | 0.0 | 0.00 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | -25.46 | NA | 55.31 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 25.1 | 25.1 | 25.0 |
| Earnings % | 0.0 | 0.0 | 0.0 |
| EPS % | 0.0 | 0.0 | 0.0 |
| EPS $ | 0.00 | 0.00 | 0.01 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -3.99 |
| Current Ratio | 0.9 |
| Quick Ratio (Acid Test) | 0.7 |
| Liquidity Ratio (Cash) | 0.01 |
| Receivables Turnover | 6.7 |
| Average Collection Period | 54 |
| Working Capital/Equity | -31.5 |
| Working Capital pS | -0.03 |
| Cash-Flow pS | -0.05 |
| Free Cash-Flow pS | -0.10 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.04 |
| Financial Leverage Ratio (Assets/Equity) | 7.9 |
| Debt Ratio | 87.3 |
| Total Debt/Equity (Gearing Ratio) | 4.14 |
| LT Debt/Equity | 0.31 |
| LT Debt/Capital Invested | 51.2 |
| LT Debt/Total Liabilities | 4.5 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 37.56 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 9.54 |
| Tobin's Q Ratio | 0.16 |
| Current P/E Ratio - LTM | 0.00 |
| Enterprise Value (EV)/EBITDA | 23.86 |
| Enterprise Value (EV)/Free Cash Flow | -22.48 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | -2.50 |
| Price/Book Ratio - LTM | 1.00 |
| Price/Cash Flow Ratio | -2.5 |
| Price/Free Cash Flow Ratio - LTM | -1.7 |
| Price/Sales Ratio | 0.05 |
| P/E Ratio (1 month ago) - LTM | 0.0 |
| P/E Ratio (26 weeks ago) - LTM | 0.0 |
| P/E Ratio (52 weeks ago) - LTM | 0.0 |
| 5-Y High P/E Ratio | 0.0 |
| 5-Y Low P/E Ratio | 0.0 |
| 5-Y Average P/E Ratio | 0.0 |
| Current P/E Ratio as % of 5-Y Average P/E | |
| P/E as % of Industry Group | 0.0 |
| P/E as % of Sector Segment | 0.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 0.0 |
| PER SHARE FIGURES |
| LT Debt pS | 0.03 |
| Current Liabilities pS | 0.54 |
| Tangible Book Value pS - LTM | -0.04 |
| Book Value pS - LTM | 0.10 |
| Capital Invested pS | 0.10 |
| Cash pS - LTM | 0.01 |
| Cash Flow pS - LTM | -0.04 |
| Free Cash Flow pS - LTM | -0.06 |
| Earnings pS (EPS) | -0.07 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -4.66 |
| Free Cash Flow Margin 5YEAR AVG | -1.97 |
| Net Profit Margin | -2.4 |
| Net Profit Margin - 5YEAR AVRG. | -4.7 |
| Equity Productivity | 24.51 |
| Return on Equity (ROE) | 0.0 |
| Return on Equity (ROE) - 5YEAR AVRG. | 0.0 |
| Capital Invested Productivity | 18.69 |
| Return on Capital Invested (ROCI) | -45.1 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | -17.2 |
| Assets Productivity | 3.30 |
| Return on Assets (ROA) | -7.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | -8.9 |
| Gross Profit Margin | 21.2 |
| Gross Profit Margin - 5YEAR AVRG. | 21.7 |
| EBITDA Margin - LTM | 1.4 |
| EBIT Margin - LTM | 0.1 |
| Pre-Tax Profit Margin | -2.5 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | -3.4 |
| Effective Tax Rate | 2.1 |
| Effective Tax Rate - 5YEAR AVRG. | -17.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 60 |
| Revenue per Employee | 1,208,122 |
| Net Income per Employee | -29,176 |
| Average Collection Period | 61 |
| Receivables Turnover | 6.7 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 1.44 |
| Assets/Revenue | 0.30 |
| Net Working Capital Turnover | -77.94 |
| Fixed Assets Turnover | 12.33 |
| Total Assets Turnover | 3.3 |
| Revenue per $ Cash | 300.00 |
| Revenue per $ Plant | 312.59 |
| Revenue per $ Common Equity | 24.51 |
| Revenue per $ Capital Invested | 18.69 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.0 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 20.3 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
